BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19242644)

  • 1. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.
    Hausenloy DJ; Ong SB; Yellon DM
    Basic Res Cardiol; 2009 Mar; 104(2):189-202. PubMed ID: 19242644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.
    Lim SY; Davidson SM; Hausenloy DJ; Yellon DM
    Cardiovasc Res; 2007 Aug; 75(3):530-5. PubMed ID: 17512507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
    Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
    Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endogenous cardioprotective mechanisms - what is it about and how does it work?].
    Beręsewicz A
    Kardiol Pol; 2011; 69 Suppl 3():59-66. PubMed ID: 22125205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mitochondria permeability transition as a target for ischemic preconditioning].
    Hoshovs'ka IuV; Shymans'ka TV; Rudyk OV; Korkach IuP; Sahach VF
    Fiziol Zh (1994); 2011; 57(4):34-45. PubMed ID: 22164407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury.
    Ong SB; Samangouei P; Kalkhoran SB; Hausenloy DJ
    J Mol Cell Cardiol; 2015 Jan; 78():23-34. PubMed ID: 25446182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
    Yadav HN; Singh M; Sharma PL
    Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
    Miura T; Tanno M
    Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconditioning and postconditioning: united at reperfusion.
    Hausenloy DJ; Yellon DM
    Pharmacol Ther; 2007 Nov; 116(2):173-91. PubMed ID: 17681609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mitochondrial permeability transition pore opening contributes to the neuroprotective effects of ischemic postconditioning in rats.
    Sun J; Luan Q; Dong H; Song W; Xie K; Hou L; Xiong L
    Brain Res; 2012 Feb; 1436():101-10. PubMed ID: 22197697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial permeability transition pore and postconditioning.
    Gateau-Roesch O; Argaud L; Ovize M
    Cardiovasc Res; 2006 May; 70(2):264-73. PubMed ID: 16581044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the MPTP in conditioning the heart - translatability and mechanism.
    Ong SB; Dongworth RK; Cabrera-Fuentes HA; Hausenloy DJ
    Br J Pharmacol; 2015 Apr; 172(8):2074-84. PubMed ID: 25393318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
    Hausenloy D; Wynne A; Duchen M; Yellon D
    Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
    Hausenloy DJ; Yellon DM
    Heart Fail Rev; 2007 Dec; 12(3-4):217-34. PubMed ID: 17541822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postconditioning: from the bench to bedside.
    Cour M; Gomez L; Mewton N; Ovize M; Argaud L
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):117-30. PubMed ID: 20938041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.
    Javadov SA; Clarke S; Das M; Griffiths EJ; Lim KH; Halestrap AP
    J Physiol; 2003 Jun; 549(Pt 2):513-24. PubMed ID: 12692185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial injury and protection in ischemic pre- and postconditioning.
    Di Lisa F; Canton M; Carpi A; Kaludercic N; Menabò R; Menazza S; Semenzato M
    Antioxid Redox Signal; 2011 Mar; 14(5):881-91. PubMed ID: 20615074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postconditioning inhibits mitochondrial permeability transition.
    Argaud L; Gateau-Roesch O; Raisky O; Loufouat J; Robert D; Ovize M
    Circulation; 2005 Jan; 111(2):194-7. PubMed ID: 15642769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent inhibition of mitochondrial permeability transition by preconditioning during the first hours of reperfusion.
    Argaud L; Loufouat J; Gateau-Roesch O; Gomez L; Robert D; Ovize M
    Shock; 2008 Nov; 30(5):552-6. PubMed ID: 18317409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release.
    Petrosillo G; Di Venosa N; Moro N; Colantuono G; Paradies V; Tiravanti E; Federici A; Ruggiero FM; Paradies G
    Free Radic Biol Med; 2011 Feb; 50(3):477-83. PubMed ID: 21130864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.